Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Metastatic Solid Tumors 1Lymphoma, Large B-Cell, Diffuse 1Colorectal Neoplasms 1Carcinoma in Situ 1Carcinoma 1Burkitt Lymphoma 1

Interventions

pembrolizumab 3Cyclophosphamide 3fludarabine 2Rosuvastatin Calcium 2Radiotherapy 2Paclitaxel 2Ipilimumab 2Interleukin-2 2Carboplatin 2spartalizumab 1peposertib 1osimertinib 1niraparib 1neotil 1necitumumab 1mirdametinib 1apatinib 1amivantamab 1Valganciclovir 1Tomography, X-Ray Computed 1Rifampin 1Radiation 1Positron-Emission Tomography 1PankoMab-GEX 1Panitumumab 1Nivolumab 1Midazolam 1Metformin 1Magnetic Resonance Imaging 1MEK inhibitor I 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumor, Adult × Tomography, X-Ray Computed × Clear all
NCT02717572 2019-04-05

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Washington University School of Medicine

Phase 1 Completed
19 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡